CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported third-quarter net income of $33.6 million.
On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of 34 cents. Earnings, adjusted for one-time gains and costs, came to 62 cents per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.
The biopharmaceutical company posted revenue of $467.2 million in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $399.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
